Asset Details
Do you wish to reserve the book?
Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk
Do you wish to request the book?
Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk
2018
Overview
ObjectivesSeveral common and rare risk variants have been reported for systemic sclerosis (SSc), but the effector cell(s) mediating the function of these genetic variants remains to be elucidated. While innate immune cells have been proposed as the critical targets to interfere with the disease process underlying SSc, no studies have comprehensively established their effector role. Here we investigated the contribution of monocyte-derived macrophages (MDMs) in mediating genetic susceptibility to SSc.MethodsWe carried out RNA sequencing and genome-wide genotyping in MDMs from 57 patients with SSc and 15 controls. Our differential expression and expression quantitative trait locus (eQTL) analysis in SSc was further integrated with epigenetic, expression and eQTL data from skin, monocytes, neutrophils and lymphocytes.ResultsWe identified 602 genes upregulated and downregulated in SSc macrophages that were significantly enriched for genes previously implicated in SSc susceptibility (P=5×10−4), and 270 cis-regulated genes in MDMs. Among these, GSDMA was reported to carry an SSc risk variant (rs3894194) regulating expression of neighbouring genes in blood. We show that GSDMA is upregulated in SSc MDMs (P=8.4×10−4) but not in the skin, and is a significant eQTL in SSc macrophages and lipopolysaccharide/interferon gamma (IFNγ)-stimulated monocytes. Furthermore, we identify an SSc macrophage transcriptome signature characterised by upregulation of glycolysis, hypoxia and mTOR signalling and a downregulation of IFNγ response pathways.ConclusionsOur data further establish the link between macrophages and SSc, and suggest that the contribution of the rs3894194 risk variant to SSc susceptibility can be mediated by GSDMA expression in macrophages.
Publisher
Elsevier Limited,BMJ Publishing Group
Subject
/ Adult
/ Basic and Translational Research
/ Child
/ DNA
/ Female
/ Genetic Predisposition to Disease
/ Genomes
/ Genomics
/ Humans
/ Hypoxia
/ Male
/ Neoplasm Proteins - genetics
/ Quantitative Trait Loci - genetics
/ RNA
/ Scleroderma, Systemic - genetics
/ Scleroderma, Systemic - pathology
/ Signal Transduction - genetics
/ Skin
/ Software
/ Trends
